Just to report that on p42 of BMJ of 9 March, there is a brief report as follows:-
"Women with ovarian cancer who take metformin seem to do better than those who do not. Preliminary analysis of a retrospective case control study (72 cases, 143 controls) indicated that the disease specific rate of survival at five years was significantly better in women taking metformin than in controls (73% v 44%, P=0.0002). Analysis excluding disease and patient factors still showed significantly improved survival at 5 years for women taking metformin (67% v 47%, P=0.007) Researchers say metformin is worthy of clinical trials in ovarian cancer (Cancer 2013;119:555-62,doi:10.1002/cncr.27706)."
For your information, Metformin is a drug which has been around for many years as a treatment (by mouth) for type 2 (maturity-onset) diabetes. Sometimes it has mild side effects of loss of appetite or nausea, but is otherwise an ok drug to take. It has been found by looking at ovarian cancer survivors who took it for other reasons - usually diabetes - that it has this effect. So there should be trials soon.
Just thought I would pass this on, as I get the BMJ (British Medical Journal) weekly.